COLUCID PHARMACEUTICALS INC - COM (CLCD)

CUSIP: 19716T101

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM
Total 13F shares
5,410,891
Share change
+95,979
Total reported value
$33,548,000
Price per share
$6.20
Number of holders
21
Value change
+$537,848
Number of buys
8
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 19716T101?
CUSIP 19716T101 identifies CLCD - COLUCID PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of COLUCID PHARMACEUTICALS INC - COM (CLCD) as of Q1 2016

As of 31 Mar 2016, COLUCID PHARMACEUTICALS INC - COM (CLCD) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,410,891 shares. The largest 10 holders included Novo A/S, PRICE T ROWE ASSOCIATES INC /MD/, EverPoint Asset Management, LLC, SPHERA FUNDS MANAGEMENT LTD., UBS OCONNOR LLC, VANGUARD GROUP INC, SG Americas Securities, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, TD ASSET MANAGEMENT INC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 21 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.